Marc Engelhardt
Chief Tech/Sci/R&D Officer bij BASILEA PHARMACEUTICA AG
Profiel
Marc Engelhardt is currently the Chief Medical Officer at Basilea Pharmaceutica AG since 2018.
Prior to this, he worked as the Director-Global Program Medical at Novartis Pharma AG.
Dr. Engelhardt completed his undergraduate and doctorate degrees at Johann Wolfgang Goethe-Universität Frankfurt am Main.
Actieve functies van Marc Engelhardt
| Bedrijven | Functie | Begin |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Chief Tech/Sci/R&D Officer | 01-01-2018 |
Eerdere bekende functies van Marc Engelhardt
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Opleiding van Marc Engelhardt
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BASILEA PHARMACEUTICA AG | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
